跳至主要内容
临床试验/CTRI/2016/02/006684
CTRI/2016/02/006684已完成2 期

Pharmaceutical Standardization Of Yashada Bhasma Prepared By Two Different Methods And Their Comparitive Efficacy On Madhumeha (Type-II Diabetes Mellitus). - T2DM

IPGT AND RA0 个研究点目标入组 92 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
92

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Both the sexes having Age between 30 years to 60 years
  • Patients having classical symptomatology of Madhumeha
  • (Prabhutamutrata, Avilamutrata etc)
  • Symptoms of Diabetes (Polyuria, Polydypsia, Polyphagia and Weight
  • Patients having Blood sugar
  • Fasting Blood Sugar ? 126 mg/dl
  • Post Prandial Blood Sugar ? 200 mg/dl

排除标准

  • 1.Age below 30 and above 65 years.
  • 2.Malignant and accelerated Hypertension.
  • 3.Patients having chronic complications of Diabetes Mellitus
  • a.Microvascular: Retinopathy, Neuropathy, & Nephropathy.
  • b.Macrovascular: Coronary artery disease, Peripheral vascular disease & Cerebro-vascular disease.
  • c.Other chronic debilitating diseases like STD etc.
  • 4.Pregnant women
  • 5.Lactating mothers
  • 6.Secondary Diabetes mellitus
  • 7.Patients of any other severe illness

研究者

发起方
IPGT AND RA

相似试验